Cancer in the Arab World

• 1 Introduction 2 General Oncology Care in Algeria 3 General Oncology Care in Bahrain 4 General Oncology Care in Egypt 5 General Oncology Care in Iraq 6 General Oncology Care in Jordan 7 General Oncology Care in Kuwait 8 General Oncology Care in Lebanon 9 General Oncology Care in Libya 10 General Oncology Care in Mauritania 11 General Oncology Care in Morocco 12 General Oncology Care in Oman 13 General Oncology Care in Palestine 14 General Oncology Care in the Kingdom of Saudi Arabia 15 General Oncology Care in Somalia 16 General Oncology Care in Sudan 17 General Oncology Care in Syria 18 General Oncology Care in Tunisia 19 General oncology care in the UAE 20 General Oncology Care in the Republic of Yemen 21 General Oncology Care in Qatar, Comoros & Djibouti 22 Breast Cancer in the Arab World 23 Colorectal Cancer in the Arab World 24 Palliative Care in the Arab World 25 Cancer Research in the Arab World 26 Pediatric Oncology in the Arab World 27 Challenges Associated with Medical Travel for Cancer Patients in the Arab World: A Systematic Review 28 Radiation Therapy in Arab World 29 Cancer Care During War and Conflict

Prof. Al-Shamsi is the director of VPS oncology services in the United Arab Emirates which is the largest cancer care provider network in the UAE. He is also the President of the Emirates Oncology Society & an adjunct professor at the college of medicine - University of Sharjah. Prof. Al-Shamsi holds triple specialty board certifications in medical oncology from the UK, USA and Canada. He completed his bachelor of science & bachelor of medicine from Cork University, the national university of Ireland with honors in 2005. He then completed his internal medicine residency followed by medical oncology fellowship, he then completed a subspecialty combined fellowship in gastrointestinal and palliative oncology at McMaster University in Canada in 2013. He then joined MD Anderson Cancer Center, The University of Texas, Houston USA as an assistant professor from 2014 to 2017. Prof. Al-Shamsi is the founder of Burjeel Cancer institute at Burjeel Medical City in Abu Dhabi, UAE which is the most comprehensive cancer center in the UAE. He has more than 70 peer reviewed articles and book chapters. His research focus is in precision medicine and health policies related to cancer care in the UAE and the Arab region. He was awarded the researcher of the year in 2020 and 2021 by the Emirates Oncology Society.
Dr. Abu-Gheida is founding head of department of radiation oncology in Burjeel Medical City and an adjunct assistant professor in the United Arab Emirates University. Dr. Abu-Gheida Radiation completed his undergraduate training where he earned a Bachelor of Science with honors degree from the American University of Beirut. Following which Dr. Abu-Gheida completed his Medical School training at the American University of Beirut Medical Center. He continued and joined the Department of Internal Medicine at the American University of Beirut. Then did his training in the Department of Radiation Oncology at the American University of Beirut Medical Center, where he served also as the chief resident. During his Training, Dr. Abu-Gheida completed a Harvard-affiliated NIH-funded research program as well. After his residency, Dr. Ibrahim went to Cleveland Clinic / Ohio, where he was appointed as an Advanced Clinical Radiation Oncology Fellow. Dr. Abu-Gheida went and joined the University of Texas MD Anderson Cancer Center. Dr. Abu-Gheida has many publications in prestigious medical journal including the American Society of Radiation Oncology official journal - International Journal of Radiation Oncology Biology and Physics, Nature, Journal of Clinical Oncology, and several others. He is also the primary author of several book chapters published in prestigious books. He also have been granted research awards during his residency.
Ms. Faryal Iqbal holds an undergraduate degree in Molecular Biology & Biotechnology. Subsequently, she earned postgraduate qualification in Molecular Genetics from Pakistan, where she worked on finding the association between XRCC1 gene polymorphism and radiation exposure in healthcare workers. She is currently working with an oncology specific research group and serving in the domains of scientific writing, data management, supervision of medical internees, and providing editorial assistance. Ms. Iqbal’s research interests and publications encompass genetics and oncology. She intends to support research across the oncology key areas including prevention, diagnosis, and treatment. Her focus is on preparing for future adoption of genomic technology and increased use of genomic information as part of the cancer diagnostic and therapeutic pathways.

Aydah Al-Awadhi is a consultant medical oncologist, graduated medical school from the United Arab Emirates University in 2012, then completed her internal medicine residency in the United States and completed her Medical Oncology and Hematology fellowship from the University of Texas, MD Anderson Cancer Center in 2019 and is American Board Certified in Hematology and Medical Oncology. She was awarded the Emirates Oncology Society (EOS) Member of the Year award, 2021. Dr. Al-Awadhi has published many articles and book chapters on breast cancer and oncology.